<?xml version="1.0" encoding="UTF-8" standalone="yes"?><drugRecordsOutput><serviceExecutionTime>342</serviceExecutionTime><Drug id="5413"><DrugName>RP-66784</DrugName><DrugSynonyms><Name><Value>RP-66784</Value><Types><Type>Research Code</Type></Types></Name></DrugSynonyms><CompanyOriginator id="19234">Rhone-Poulenc SA</CompanyOriginator><CompaniesSecondary><Company id="19234">Rhone-Poulenc SA</Company></CompaniesSecondary><CrossReferences><SourceEntity id="5413" type="Drug"><TargetEntity id="174774" type="siDrug">RP-66784</TargetEntity></SourceEntity><SourceEntity id="19234" type="Company"><TargetEntity id="4297429768" type="organizationId">Rhone-Poulenc Biochimie SA</TargetEntity></SourceEntity><SourceEntity id="178" type="ciIndication"><TargetEntity id="10020772" type="MEDDRA"></TargetEntity><TargetEntity id="D006973" type="MeSH"></TargetEntity><TargetEntity id="-369992864" type="omicsDisease"></TargetEntity><TargetEntity id="240" type="siCondition"></TargetEntity></SourceEntity><SourceEntity id="23" type="ciIndication"><TargetEntity id="I20" type="ICD10"></TargetEntity><TargetEntity id="10002383" type="MEDDRA"></TargetEntity><TargetEntity id="D000787" type="MeSH"></TargetEntity><TargetEntity id="-1965112918" type="omicsDisease"></TargetEntity><TargetEntity id="223" type="siCondition"></TargetEntity></SourceEntity><SourceEntity id="313" type="Action"><TargetEntity id="1644" type="Mechanism">Calcium-Activated K(Ca) Channel Activators</TargetEntity><TargetEntity id="364" type="Mechanism">Potassium Channel Activators</TargetEntity></SourceEntity></CrossReferences><PhaseHighest id="DX">Discontinued</PhaseHighest><PhaseTerminated id="NDR">No Development Reported</PhaseTerminated><IndicationsSecondary><Indication id="178">Hypertension</Indication><Indication id="23">Angina</Indication></IndicationsSecondary><ActionsPrimary><Action id="313">Potassium channel stimulator</Action></ActionsPrimary><ActionsSecondary><Action id="2657">Antihypertensive</Action></ActionsSecondary><Technologies><Technology id="762">Small molecule therapeutic</Technology></Technologies><EphmraCodes><Ephmra><Code>C2</Code><Name>ANTIHYPERTENSIVES</Name></Ephmra></EphmraCodes><LastModificationDate>2017-09-04T03:41:15.000Z</LastModificationDate><ChangeDateLast>2002-03-21T15:38:39.000Z</ChangeDateLast><AddedDate>1996-02-16T00:00:00.000Z</AddedDate><DevelopmentProfile><Summary><displayLabel>Summary</displayLabel><value>&lt;Summary&gt;&lt;para&gt;&lt;ulink linkID="5413" linkType="Drug"&gt;RP-66784&lt;/ulink&gt; is a potassium channel activator which was under development by Rhone-Poulenc as a potential treatment for angina and hypertension; development has now been discontinued [&lt;ulink linkID="266495" linkType="reference"&gt;266495&lt;/ulink&gt;].&lt;/para&gt;&lt;/Summary&gt;</value></Summary></DevelopmentProfile><IDdbDevelopmentStatus><DevelopmentStatusCurrent><Company id="19234">Rhone-Poulenc SA</Company><Country id="FR">France</Country><DevelopmentStatus id="DX" sortOrder="4">Discontinued</DevelopmentStatus><DiscontinuedReason id="4">Not Reported</DiscontinuedReason><Indication id="23">Angina</Indication><StatusDate>1997-10-17T00:00:00.000Z</StatusDate><Source id="266495" type="CORPORATE"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="19234">Rhone-Poulenc SA</Company><Country id="FR">France</Country><DevelopmentStatus id="DX" sortOrder="4">Discontinued</DevelopmentStatus><DiscontinuedReason id="4">Not Reported</DiscontinuedReason><Indication id="178">Hypertension</Indication><StatusDate>1997-10-17T00:00:00.000Z</StatusDate><Source id="266495" type="CORPORATE"/></DevelopmentStatusCurrent><DevelopmentStatusHistoric><Company id="19234">Rhone-Poulenc SA</Company><Country id="FR">France</Country><DevelopmentStatus id="NDR" sortOrder="3">No Development Reported</DevelopmentStatus><Indication id="23">Angina</Indication></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="19234">Rhone-Poulenc SA</Company><Country id="FR">France</Country><DevelopmentStatus id="NDR" sortOrder="3">No Development Reported</DevelopmentStatus><Indication id="178">Hypertension</Indication></DevelopmentStatusHistoric></IDdbDevelopmentStatus><Targets><Target id="PTGT-01591"><Name>Potassium channel</Name><SwissprotNumbers/></Target></Targets><ReasonsForUpdate><ReasonForUpdate><Reason>Development Status Updated</Reason><Description>One or more development status entries have been updated</Description></ReasonForUpdate><ReasonForUpdate><Reason>Indexing Updated</Reason><Description>Indexing updated</Description></ReasonForUpdate></ReasonsForUpdate><StructureSmiles><Smiles>CNC(=S)[C@]1(CCCC[C@@H]1CCNS(=O)(=O)c2ccccc2)c3cccnc3</Smiles></StructureSmiles><hasSWOTs>N</hasSWOTs></Drug></drugRecordsOutput>